share_log

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-JPMORGAN CHASE & CO.(4.0%)

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-JPMORGAN CHASE & CO.(4.0%)

SC 13G/A:超過5%持股股東披露文件(修正)-JPMORGAN CHASE & CO.(4.0%)
美股sec公告 ·  06/07 12:11
Moomoo AI 已提取核心訊息
JPMorgan Chase & Co. has filed an amended Schedule 13G with the United States Securities and Exchange Commission on June 7, 2024, indicating a change in their holdings of Exact Sciences Corporation. The filing reveals that JPMorgan now beneficially owns 7,521,686 shares of Exact Sciences Corporation, which represents 4.0% of the company's class of common stock. This marks a decrease in ownership, as the filing indicates that JPMorgan has ceased to be the beneficial owner of more than five percent of the class of securities. The shares are held across various JPMorgan entities, including J.P. Morgan Trust Company of Delaware and J.P. Morgan Securities LLC, among others. The filing asserts that the shares were acquired and are held in the ordinary course of business, not with the intention of changing or influencing the control of Exact Sciences Corporation.
JPMorgan Chase & Co. has filed an amended Schedule 13G with the United States Securities and Exchange Commission on June 7, 2024, indicating a change in their holdings of Exact Sciences Corporation. The filing reveals that JPMorgan now beneficially owns 7,521,686 shares of Exact Sciences Corporation, which represents 4.0% of the company's class of common stock. This marks a decrease in ownership, as the filing indicates that JPMorgan has ceased to be the beneficial owner of more than five percent of the class of securities. The shares are held across various JPMorgan entities, including J.P. Morgan Trust Company of Delaware and J.P. Morgan Securities LLC, among others. The filing asserts that the shares were acquired and are held in the ordinary course of business, not with the intention of changing or influencing the control of Exact Sciences Corporation.
摩根大通於2024年6月7日向美國證券交易所委員會提交了修訂後的13G表格,表明其持股Exact Sciences Corporation的情況發生了變化。該提交揭示了摩根大通現在擁有了Exact Sciences Corporation的7,521,686股股份,佔公司普通股的4.0%。這標誌着持股量的下降,因爲提交表明摩根大通已經不再持有佔證券類別五分之一以上的權益。股份被持有在各種摩根大通實體中,包括特拉華州J.P. Morgan Trust Company和J.P. Morgan Securities LLC等。提交表明,這些股份是在業務的正常過程中獲得和持有的,不是爲了改變或影響Exact Sciences Corporation控制權。
摩根大通於2024年6月7日向美國證券交易所委員會提交了修訂後的13G表格,表明其持股Exact Sciences Corporation的情況發生了變化。該提交揭示了摩根大通現在擁有了Exact Sciences Corporation的7,521,686股股份,佔公司普通股的4.0%。這標誌着持股量的下降,因爲提交表明摩根大通已經不再持有佔證券類別五分之一以上的權益。股份被持有在各種摩根大通實體中,包括特拉華州J.P. Morgan Trust Company和J.P. Morgan Securities LLC等。提交表明,這些股份是在業務的正常過程中獲得和持有的,不是爲了改變或影響Exact Sciences Corporation控制權。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息